MG
LIAN

Michael Gelband’s LianBio American Depositary Shares LIAN Stock Holding History

Michael Gelband’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-119,453
Closed -$736K – 2786
2021
Q4 		$736K Buy
+119,453
New +$1.36M 0.01% 1229

Other funds holding LIAN

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $2.48B AUM 8.43% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Michael Gelband's LIAN Position: Q1 2022 in Review

Michael Gelband sold out of LianBio American Depositary Shares (LIAN) in Q1 2022, closing a stake of 119,453 shares — an estimated $736K sold.

Michael Gelband first reported a position in LIAN in Q4 2021 and held it in 1 quarter. The position peaked at $736K in Q4 2021. 37 funds tracked by Wall St. Rank hold LIAN as of Q1 2022.

  • Michael Gelband reported no remaining LianBio American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Michael Gelband sold 119,453 LianBio American Depositary Shares shares in Q1 2022, an estimated $736K.
  • Michael Gelband first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Michael Gelband's LianBio American Depositary Shares position peaked at $736K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.